Medicine recalls
|
| |
| Canada: Jamp-Atorvastatin 40 mg tablets recalled due to risk of latex contamination |
| |
Health Canada announces that Jamp Pharma Corporation is recalling one lot of Jamp-Atorvastatin 40 mg tablets (lot number: MHC1403A) due to possible contamination with latex pieces during manufacturing. A piece of latex was found in one tablet from the affected lot.
Ingesting latex can pose serious health risks for people with latex allergies, including severe allergic reactions (anaphylaxis). Symptoms of anaphylaxis include breathing difficulties, nausea, vomiting, and low blood pressure. Anaphylaxis can be life threatening. In addition, foreign material in the tablets may change their shape, which could make them difficult to swallow and lead to choking.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/jamp-atorvastatin-40-mg-tablets-recalled-due-risk-latex-contamination
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Monday, Aug 8, 2022
Issued at HKT 14:30
|
| |
